Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |